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Abstract 14 
Tobacco smoke has harmful effects on a multi-organ level. Exposure to smoke, 15 
whether in utero or environmental, significantly increases susceptibility. This susceptibility 16 
has been identified to be divergent between males and females. However, there remains 17 
a distinct lack of thorough research into the relationship between sex and exposure to 18 
tobacco. Females tend to generate a more significant response than males during 19 
adulthood exposure. The intrauterine environment is meticulously controlled, and 20 
exposure to tobacco presents a significant factor that contributes to poor health outcomes 21 
and susceptibility later in life. Analysis of these effects in relation to the sex of the offspring 22 
is yet to be holistically reviewed and summarised. In this review, we will delineate the 23 
time-dependent relationship between tobacco smoke exposure and sex-specific disease 24 
susceptibility. We further outline possible biological mechanisms that may contribute to 25 
the identified pattern. 26 
  27 
Sex-Specific effects of in utero and adult tobacco smoke 28 
exposure 29 
Background 30 
The intrauterine environment is highly regulated to enable healthy fetal 31 
development. Alterations to the molecular and chemical milieu predispose the fetus to 32 
chronic diseases later in life. The 'developmental origins of disease' hypothesis describes 33 
that changes to prenatal conditions induces adaptions which alter anatomical structure 34 
and physiology to promote growth and success (27). These adaptations, although aiding 35 
intrauterine survival, may not offer protection perinatally (27). A recent review details the 36 
effects of maternal exposure to heavy metals, stress, tobacco smoke, and alcohol on the 37 
health outcomes of offspring (17), identifying that tobacco smoking negatively impacts 38 
multiple organ systems (17). 39 
Tobacco smoking is a leading risk factor for non-communicable diseases (NCDs). 40 
Although on the decline, smoking rates remain high worldwide. Smoke exposure remains 41 
the leading preventable cause of chronic diseases such as chronic obstructive pulmonary 42 
disease (COPD), cancer, and congenital heart disease (CHD) (3, 22, 38). Approximately 43 
50% of women who smoke continue after discovering they are pregnant (48). As such, 44 
maternal tobacco smoke (MTS) is the leading preventable cause of abnormal pregnancy 45 
outcomes (48). MTS increases the likelihood of the newborn to suffer from various NCDs 46 
in childhood and adulthood (6, 45, 54, 62). The biological mechanism driving this is yet to 47 
be elucidated however hormones, epigenetics, oxidative stress, and DNA mutations have 48 
all been postulated. 49 
Active smoking has an overall adverse health impact, and sex-specific effects are 50 
recognised.  Adult tobacco smoking has greater consequences in females, suffering 51 
higher morbidity, and greater severity of tobacco-related disease (44). A meta-analysis 52 
found smoking intensity increased the magnitude and likelihood of stroke in women 53 
compared to men (53). Females had increased risk and severity of COPD and colorectal 54 
cancer with similar smoking levels (3, 22). Despite a clear pattern in adulthood, sex-55 
specific prenatal effects of tobacco smoke exposure are rarely investigated appropriately 56 
or thoroughly.  57 
This review aims to highlight the importance of fetal sex in response to tobacco 58 
smoke exposure in utero and compare these patterns to adult smoke exposure. 59 
Sex Differences in Development 60 
Sexual dimorphism exists in utero, with the male and female fetus' undergoing 61 
distinct physiological and developmental processes. This is apparent in lung 62 
development. Lung maturation is advanced in female fetuses, with mouth movement and 63 
surfactant production starting at 18 weeks, whereas males reach this milestone after 20-64 
23 weeks (54, 56). As a result, the female fetus can generate a robust response to various 65 
exposures (56). The phenomenon of dysanapsis describes differences in fetal lung 66 
development between the sexes. Male lungs have larger but fewer airways, while females 67 
have more abundant yet smaller airways, enabling higher airflow rates (32). Increased 68 
flow-rate enables greater adaptability in females to cope with adverse environments, 69 
sustaining stable growth. This phenomenon persists until 18 years of age, when male 70 
lung function overtakes females (32). The cause of delayed lung growth in males is 71 
unknown. It is a leading factor predisposing pre-pubertal males to asthma and lower 72 
respiratory tract infections (LRTI) (55), from which young females appear to be protected.  73 
Sex differences in fetal brain, heart, and overall growth also exist. Genes located 74 
on the male-specific Y-chromosome drive sexual dimorphism in brain development (65) 75 
The SRY gene, primarily known for testicular maturation (65), controls a cascade of 76 
androgens regulating male brain development in utero (14). As evidence of dimorphism, 77 
boys are liable to the creation of white matter by androgen stimulation; on the other hand, 78 
estrogen in females is inhibitory (14). Fetal heart rate patterns also differ, highlighting a 79 
divergence in male and female development. Males demonstrate increased heart-rate 80 
variability (16), implying a lack of stability in growth compared to females. 81 
Here, we present inherent differences between the sexes in the absence of 82 
exogenous influences. However, the presence of this sexual dimorphism may leave either 83 
sex more susceptible to the effects of in-utero exposure to external toxicants.  84 
Sex-Specific susceptibility due to Tobacco Smoke 85 
Modern medicine strives to design patient-specific 'personalised medicine.' The 86 
ideology is based on the heterogeneity of symptoms, pathology, and response to 87 
treatment. This concept explains why interventions are effective for some individuals, yet 88 
ineffective for others. As such, precise and distinct mechanisms regulate physiological 89 
processes in everyone. Although sex is a fundamental characteristic, it is widely 90 
overlooked or under-investigated as a determining factor in disease and is considered a 91 
co-variate or confounding factor. As such, limited thorough research exists investigating 92 
sex-specific effects of MTS and adult tobacco smoke exposure on disease susceptibility. 93 
Here we will detail sex-specific pathological sensitivity due to both in utero and adult 94 
tobacco exposure. 95 
Lung Function Decline 96 
The process of dysanapsis is well-described and closely linked to sex differences 97 
in respiratory outcomes (5, 76, 79). Males have decreased lung function compared to 98 
females who consistently have higher maximal expiratory flow at functional residual 99 
capacity (V'max FRC) perinatally (76, 83).  MTS compounds this sex difference in lung 100 
function, as shown by various cohort studies. A study of 6,740 Chinese children reported 101 
independent negative correlation between MTS and post-natal smoke exposure on lung 102 
function, with a greater response in males overall. Male adjusted odds ratio (OR) for 103 
decreased forced vital capacity (FVC) in response to MTS  OR6.46 (95% confidence 104 
interval (CI) 2.58 - 16.17) compared to  the female OR 2.16 (95% CI 0.96 - 4.88) (35). 105 
Interestingly, this authors note an apparent protective effect of asthma diagnosis, with 106 
non-asthmatic offspring presenting a more pronounced decrease in lung function 107 
outcomes (35). A large North American cohort found male MTS-exposed offspring 108 
consistently experience worse lung function outcomes (FEV1, FEV1/ FVC, FEF65-75%) than 109 
female counterparts, when measured from 8 – 12 years (15). Therefore,  MTS has a 110 
lasting impact on lung development throughout childhood. The study is limited by its 111 
sample size of MTS exposed children, most likely caused by underreporting of smoking 112 
by mothers, reducing the ability differentiate MTS from postnatal smoke exposure. 113 
Nonetheless, a reduction in male offspring lung function from MTS is supported by 114 
multiple case-control cohort investigations (19, 31, 47, 52).  115 
Chronic Obstructive Pulmonary Disease 116 
COPD is primarily an adult-onset disease, instigated by long-term exposure to 117 
noxious gases causing chronic progressive lung function decline (70). As such, it is 118 
challenging to associate MTS to COPD incidence as it is near impossible to differentiate 119 
prenatal influence from life-long exposures. Generally, males report increased COPD 120 
incidence; however, evidence supports greater female susceptibility (26). A cross-121 
sectional US cohort study, concluded a significantly greater percentage (64%) of adults 122 
diagnosed with COPD were female from a cohort of 2,113 patients, possibly due to 123 
lifetime environmental tobacco exposure(22). The authors also report no significant 124 
relationship between MTS and COPD incidence (p = 0.051). Foreman et al. (2011), , find 125 
females predominate early-onset COPD due to adult exposure (26). An alternative 126 
perspective and interpretation was presented by a recent systematic review of 16 studies, 127 
the authors assert MTS impairs physiological development and hence lung function 128 
resulting in an increased risk of COPD development in adulthood (67). Therefore, as there 129 
is a male-biased effect of MTS on lung function decline, men are predisposed towards 130 
COPD development later in life. However, the age window of susceptibility may vary 131 
between the sexes (71), requiring further investigation.  132 
Asthma 133 
The pattern of male sex being predominately affected by MTS disappears when 134 
investigating asthma. A large Australian cohort reported that when mothers smoke more 135 
than a pack a day, female offspring had an almost two-fold increased risk of asthma; OR 136 
1.96 (95% CI 1.25 - 2.08) (1). Males showed no association between MTS and asthma 137 
at any age, with asthma risk-reducing upon postnatal smoke exposure (1). A Finnish 138 
study investigated the effect of mothers smoking greater than and less than 10 cigarettes 139 
during pregnancy, and identified no significant difference in asthma incidence between 140 
the sexes. A higher crude OR for female offspring of smoking mothers, although, males 141 
demonstrate higher cumulative incidence of asthma irrespective of maternal smoking 142 
level (39).During prepubescence, males dominate asthma incidence. At puberty, this 143 
pattern reverses, and females dominate diagnoses with an increase in female cases 144 
rather than a decline in male cases, with disease incidence equalising post-menopause  145 
(61). This natural pattern confounds many MTS asthma studies, which assess asthma 146 
diagnosis at age 14. As such, it is difficult to determine a definitive sex-link between MTS 147 
and asthma. Thus, the methodology of future studies requires careful consideration to 148 
sufficiently differentiate the temporal incidence of asthma with the effects of MTS. In 149 
general, women are more likely to use healthcare compared to men when matching for 150 
asthma status, indicating worse disease prognosis (44). Asthmatic females have greater 151 
bronchial hyper-responsiveness to cigarette smoke, highlighting another sexual 152 
dimorphism (44). In support, a large Swedish cohort, found smoking increases female 153 
relative risk of adult-onset asthma with an increased rate ratio 1.3 (95% CI 1.0 – 1.6) 154 
compared to men (74). Therefore, the respiratory effects of adult smoke exposure are 155 
more pronounced in women.  156 
Multi-Organ Effects 157 
Sexual dimorphism in disease susceptibility due to tobacco smoke exposure 158 
extends beyond the respiratory system, having multi-organ disease influences. Childhood 159 
cancers such as leukemia, childhood brain tumors (CBT), and lymphomas report higher 160 
incidence in boys than girls (6). Adult female smokers have a greater rate of cancer, 161 
despite lower smoking intensity than males (3). Anderson et al. (2010) found a statistically 162 
significant increased risk of advanced colorectal neoplasia for mild smoking (10-30 pack 163 
years) females OR 4.11 (95% CI 1.88 – 9.01). Males only show increased disease 164 
development risk with heavy smoking (≥ 30 pack years) OR 3.10 (95% CI 1.71 – 5.65), 165 
which is similar to females at this smoking intensity (3). This contrasts with prenatal 166 
exposure closely which is linked to increased risk of disease in males. Tettamanti et al. 167 
(2016), identified in a large Swedish cohort, that smoking during pregnancy indicated a 168 
trend towards increased childhood brain tumor incidence in male children aged between 169 
five and nine years old, with a non-significant OR 1.23 (95% CI 0.91 – 1.67) (73). A recent 170 
review supports this trend asserting that nicotine affects the male brain development 171 
greater than in females (14). However, in contrast, large cohort studies find either a slight 172 
increase or no link between MTS and the development of CBT (28, 78).  173 
Intellectual and social disability is linked to the action of nicotine on fetal brain 174 
development (14). Meta-analyses and cohort studies find increased male susceptibility to 175 
intellectual disability (36, 37). MTS is asserted to primarily affect brain microstructure in 176 
males, causing less-coherent fibers and myelination (13). This male-dominated risk is 177 
attributed to genetic differences defined by the Y-chromosome (not present in females), 178 
resulting in differential expression of genes in specific brain regions (65).  179 
Smoke exposure increases congenital heart disease (CHD) risk with teratogenic 180 
effects during early pregnancy fetal heart development. The incidence of CHD is higher 181 
in children of smokers (60.9%) compared to non-smokers (35.8%) (42). A study of 365 182 
neonates found an increased OR 2.75 (95% CI 1.66 – 4.58) of CHD due to peri-183 
conceptual smoking, increasing with smoking intensity (42). Thus, the effects of tobacco 184 
smoke are highly persistent, possibly affecting gametes. A Brazilian longitudinal cohort at 185 
follow-up, found female offspring exposed to MTS presented decreased HDL levels (33). 186 
Although an indirect indicator, the authors assert females may be more sensitive to 187 
cardiovascular disease due to MTS, due to reduced circulating HDL. Another study found 188 
that the female offspring of smokers had lower HDL levels than males in a large British 189 
cohort (62). These findings are reported in adult females, without pediatric effects of MTS 190 
exposure reported, limiting the ability to make conclusions regarding the life-long effects 191 
of smoke exposure. Adult female smokers have an overall increased risk of 192 
cardiovascular disease, supported by a 50% increased risk of myocardial infarction due 193 
to smoking (38, 63). Male mice offspring exposed to prenatal nicotine demonstrated a 194 
higher risk of hypertension and increased arterial thickness, with no significant effect 195 
observed for females (82). Alexander et al. (2011) assert that precise timing of in utero 196 
exposures significantly impacts the subsequent cardiovascular outcome (2), accounting 197 
for significant variability in the findings of the literature relating to cardiovascular disease. 198 
Sex-Specific susceptibility due to E-Cigarette Exposure 199 
 The recent popularity of e-cigarettes or vapes as an alternative to traditional 200 
tobacco smoking is important to acknowledge. Due to their perception of being “safer”, e-201 
cigarettes usage in pregnancy equals tobacco cigarette consumption (80). A detailed 202 
review of 800 articles Limited studies of the long-term physiological effects of e-cigarette 203 
products exist. McGrath-Morrow et al. (2015) identify a modest impairment of lung growth 204 
by neonatal e-cigarette exposure but do not investigate any effect of sex (49). An 205 
epidemiological study reported males comprise approximately 69% of patients suffering 206 
lung injury associated with vaping, indicating a greater pathogenic effect in males (59). A 207 
deleterious multi-organ effect driving increased inflammatory response and cytotoxicity 208 
supported by clinical and in vitro studies (8, 23). Striking similarities between tobacco and 209 
e-cigarettes responses  warrants further research of the long-term and sex-specific 210 
effects of e-cigarettes.  Across all NCDs discussed, the effect of MTS was weakened 211 
with age (11), indicating a more substantial impact on pediatric outcomes and less of a 212 
life-long impact. We have identified a distinctive male predominate effect of prenatal 213 
smoke exposure with higher incidence and susceptibility across multiple organ systems. 214 
Some studies report MTS-related effects in females; however, this is confounded by 215 
unaccounted post-natal environmental and biological factors. The male fetus appears to 216 
be more susceptible to the adverse effects of tobacco smoke, while female fetuses are 217 
protected. This protection only lasts for the childhood years, with adult females 218 
consistently experiencing more extreme forms of chronic disease from tobacco smoke 219 
exposure (3, 12, 76). Our findings are summarised in Table 1.  220 
Table 1: Summary of sexual dimorphism in disease susceptibility due to tobacco 221 







• Tettamanti et al. 2016 (73) Male Male 
• Botsivali & Kyrtopoulos 2019  (6) Male  
• Anderson et al. 2011 (3)  Female 
• Drake et al. 2015 (21) Male  
Respiratory 




• Dotterud et al. 2013 (20) Male  
• Hu et al. 2017 (35)  Male  
• Cunningham, Dockery & Speizer 1994 
(15) 
Male  
• Hayabakhsh et al. 2009 (31) Male  
• Toren & Hermansson 1999 (74)  Female 
• Kynyk, Mastronarde & McCallister 
2011 (44) 
 Female 
• Miller et al. 2014 (51) Femal
e 
 
• Moshammer et al. 2006 (52) Male  
• Eisner et al. 2005 (22)  Female 
• Foreman et al. 2011 (26)  Female 
 
•    
Neurological 
Conditions 
• Hutchinson et al. 2009 (37) Male  
• Cross, Linker & Leslie 2017 (14) Male  
• Appelman et al. 2015 (4)  Female 
• Peters, Huxley & Woodward 2013 (60)  Female 
• Chang et al. 2016 (13) Male  
Cardiovascular 
Diseases 
• Power, Atherton & Thomas 2010 (62) Femal
e 
 
• Horta et al. 2011 (33) Femal
e 
 
• Prescott et al. 1998 (63)  Female 
• Huxley & Woodward 2011 (38)  Female 
• Xiao et al. 2008 (82) Male  
Mechanisms of Susceptibility 223 
Cleary, sexual dimorphism exists in disease susceptibility due to tobacco smoke 224 
exposure. Importantly, the affected sex differs depending on in utero verse adulthood 225 
exposure. Here, we outline possible mechanisms that may contribute to sex differences.  226 
Sex Steroid Hormones 227 
 Hormones are a critical biological factor responsible for various phenotypic 228 
differences between males and females. The primary male hormones are androgens 229 
(testosterone), while in females; estrogens (estradiol) predominate, although both 230 
function in either sex. Estrogens are pro-inflammatory increasing production of pro-231 
inflammatory cytokines such as TNF-α, IFN-γ and IL-12, while downregulating the anti-232 
inflammatory cytokine IL-10 (68). Androgens have the opposite effect, increasing IL-10 233 
levels and suppressing production of IFN-γ (68). Increased estrogen levels correlates with 234 
greater production of cytochrome P450 enzymes; central to the metabolism of tobacco 235 
into toxic intermediaries (72). As result, there is accelerated production of oxidative smoke 236 
metabolites, which contribute to lung injury and inflammation. The prevalence and 237 
strength of the estrogen's effects change over time. Mature young females generate a 238 
more robust immune response, compared to males and older women, which is attributed 239 
to higher blood estrogen levels (58). The immune response in male mice is increased 240 
with exogenous estrogen, indicating a similar function of the hormone in both sexes (50, 241 
68). Conversely, androgens act to suppress the innate immune response up-regulating 242 
IL-10 production (30).  Maternal testosterone levels are increased by 11% higher in 243 
smokers, whilst no effect is seen for estrogen (75). Generally, post-menopausal women 244 
tend to response similar to males with estrogen levels declining with age. However, this 245 
remains an understudied phenomenon. Brand et al. (2011) find tobacco increases 246 
circulating levels of both male and female associated hormones in post-menopausal 247 
women but do not compare to perimenopause (9). Therefore, a close relationship exists 248 
between tobacco smoke exposure and sex hormone levels in circulation. 249 
Epigenetics  250 
Males and females have comparable genomes, except for the male-specific Y-251 
chromosome; therefore, sex-biased gene regulation is likely to occur. Our group has 252 
previously shown that sexual dimorphism is maintained ex vivo (64), supporting the notion 253 
that an internal mechanism other than hormones drive observed sex differences. MTS is 254 
well-established to alter the epigenome causing adverse effects in the lung (84). 255 
Epigenetics is well-established as a mechanism influencing transcription, showing clear 256 
sexual-dimorphism in utero (46, 54). Ladd-Acosta et al. (2016) describe MTS-induced 257 
sex-specific methylation patterns, where MTS-exposed female preschoolers had 258 
increased methylation, with decreased methylation in males near the HLA-DPB2 gene 259 
locus (46). Other studies identify that  genes involved in the immune response and 260 
defense against infection are altered in female infants, while genes regulating cancer, 261 
developmental and neurological processes are affected in male infants (43). This partially 262 
explains why males incur more developmental problems, particularly in childhood, 263 
whereas, women experienced more smoking-induced chronic inflammatory diseases in 264 
adulthood. Many smoking-related genes are differentially methylated in utero with AHRR 265 
and CYP1A1; both central in tobacco smoke metabolism, and GFI1; which is essential 266 
role to developmental processes and histone modification, (41). Of significance, 267 
differential methylation caused by smoking shows no differences between males and 268 
females in whole blood (86). Upon deeper investigation, the authors identify that males 269 
have an increased tendency for DNA methylation alteration, with 42 differentially 270 
methylated sites in males compared to 10 sites in females. Females demonstrate 271 
alteration to immune-related genes due to adult smoke exposure, such as CCL13, CCL2, 272 
and FCN1  (18). Breitling et al. (2011) assert that sexual dimorphism of DNA methylation 273 
does not occur due to adulthood tobacco smoke exposure (10). Figure 1 highlights this 274 
dynamic relationship between MTS and gene expression in utero presents as highly 275 
valuable future research pathways to generate a holistic picture between sex, the 276 
epigenome, and tobacco smoke.  277 
Figure 1: Sexual dimorphism in epigenetic changes between males and females depending 278 
on the time of tobacco smoke exposure. ♂ = male specific effect, ♀ = female specific effect. 279 
 280 
Telomere Length 281 
Telomeres are complicated nucleotide sequences located at the end of 282 
chromosomes, functioning in cell division, chromosome stabilisation, and apoptosis (66). 283 
Telomere length (TL) contributes to a variety of diseases. Shorter TL is linked with 284 
atherosclerosis and cardiovascular diseases, while long TL is associated with cancers as 285 
cellular longevity is increased (25). An association between the sex-specific relationship 286 
between telomere length and smoking has been identified, and is summarised in Figure 287 
2. MTS is linked with shorter TL in males (24). However, studies also find females 288 
generally have longer TL than males across all ages, confounding these findings (25). An 289 
in vitro investigation of telomeres in cord blood found only male telomere length was 290 
negatively affected by smoke exposure in utero (24). The generally longer TL in females 291 
may enable more stability and resilience to exposures, subsequently offering protection 292 
from short TL-associated diseases postnatal (29). Therefore, it is pertinent to investigate 293 
how smoking directly influences TL and its link to sex-specific disease susceptibility.  294 
Figure 2: Sexual dimorphism in the effect of tobacco smoke exposure on telomere length 295 
depending on the time of exposure between males and females. ♂ = male specific effect, ♀ 296 
= female specific effect. 297 
 298 
Mitochondria 299 
Mitochondria produce the energy currency of the cell adenosine-tri-phosphate 300 
(ATP). But, mitochondrial functions extend beyond ATP energy production from hormone 301 
synthesis to ionic regulation and apoptosis (77). The breakdown of mitochondria 302 
bioenergetics in utero impacts various biological processes, proving detrimental to fetal 303 
health. Tobacco smoke stimulates increased mitochondrial DNA copy number to 304 
compensate for a decline in cellular respiratory function (34). MTS induces a breakdown 305 
in enzymatic activity of placental mitochondria (7), negatively impacting the ability to 306 
sustain optimum intrauterine conditions. Toxic products in tobacco smoke accumulate in 307 
the placenta (7), with tobacco smoke metabolized at a higher rate in the fetus. Therefore, 308 
the interaction between smoking by-products: CO, nicotine, and thiocyanate contributes 309 
to a breakdown in mitochondrial function (7). Our group recently found male mice 310 
offspring exposed to smoke in utero showed an increase in mitophagy markers (Drp-1 311 
and Opa-1, while no effect was seen in females (57). These proteins are markers of 312 
mitochondrial fission and fusion, dysregulation of these markers can correlate with 313 
disease severity through altered airway structure and function in asthma and COPD.. 314 
Optimised function of mitochondria in females was recognised in peripheral blood 315 
mononuclear cells, where significantly greater mitochondrial activity was reported in 316 
women (69). It is hypothesised that as mitochondria are maternally inherited, spending 317 
more time under selection in females they are optimised for function in females rather 318 
than males. Due to a greater functional ability female mitochondria may have more 319 
resilience and improved ability to respond to stressors such as environmental smoke, 320 
protecting females from reactive oxygen species (ROS) and oxidative stress. Ventura-321 
Clapier et al. (2017) thoroughly detail the tissue and sex specificity of mitochondria (77). 322 
Figure 3 illustrates temporal sex differences of mitochondrial response, highlighting that 323 
the mitochondria may significantly contribute to the disparity in disease susceptibility 324 
between the sexes  and warrants more in-depth investigation.  325 
Figure 3: Sexual dimorphism in mitochondrial responses between adult males and 326 
females, and sex-specific effects of prenatal tobacco smoke exposure on fetal 327 
mitochondria. ♂ = male specific effect, ♀ = female specific effect. 328 
Conclusions 329 
The intrauterine environment is a highly regulated and dynamic milieu of factors. 330 
Hence, exposure of the fetus to tobacco smoke threatens outcomes for the offspring. We 331 
have reviewed sexual dimorphism in disease susceptibility with the time of tobacco 332 
smoke. We found compounding evidence that male offspring exposed to cigarette smoke 333 
in utero have increased sensitivity to disease development in multiple organ systems, 334 
with this trend reversed in adult exposure, where females show greater susceptibility (4). 335 
Therefore, a distinct sexual dimorphism exists regarding the effects of tobacco smoke 336 
exposure, with the time of exposure having a defining impact, as illustrated in Figure 4 337 
and Figure 5. 338 
We have also discussed possible biological mechanisms driving sexual 339 
dimorphism. Sex hormones, epigenetics, telomere length, and the mitochondrial 340 
response may contribute either independently or concurrently to the sex disparity. Other 341 
possible mechanisms not discussed include, genetic polymorphisms, chromosomal 342 
aberrations, and the sex chromosomes. As a distinct temporal switch in sex-susceptibility 343 
exists, it is possible different mechanisms function at different life-stages. Future research 344 
must focus on the timing and intensity of exposures to develop a holistic understanding. 345 
The outcomes of subsequent mechanistic studies can inform clinical responses, enabling 346 
patient-specific interventions, and more effective treatments.  347 
Figure 4: Schematic summarising molecular mechanisms contributing to sex differences 348 
in disease susceptibility of offspring in response to maternal tobacco smoke exposure.    349 
♂ = male specific effect, ♀ = female specific effect. 350 
351 
Figure 5: Schematic summarising molecular mechanisms contributing to sex differences 352 
in disease susceptibility caused by adulthood tobacco smoke exposure. ♂ = male specific 353 
effect, ♀ = female specific effect. 354 
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